Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Explore linked clinical trials.33 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer | Advanced Non-Small Cell Lung Cancer | Active, not recruiting | Phase 2 | 2026-07-15 | NCT04922658 | |
| Second-Line Sacituzumab Tirumotecan Plus Anlotinib for Advanced Driver Gene-Negative Non-Squamous NSCLC | Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 2 | 2026-07-14 | NCT07703228 | |
| A Prospective Study on the Diagnosis of Malignant Tumors With 18F-FGIn PET/CT | neoplasm | Recruiting | Not stated | 2026-05-22 | NCT07602569 | |
| Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid | Nasopharyngeal Cancinoma (NPC); Radiation-induced Oral Mucositis | Recruiting | Phase 3 | 2026-05-07 | NCT07311772 | |
| Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal Carcinoma | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Recruiting | Phase 3 | 2026-04-30 | NCT04944914 | |
| PaCIFiC-CUP Classifies Cancer of Unknown Primary | Neoplasm Metastasis, Neoplasms, Unknown Primary, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Unknown Primary Tumors, neoplasm | Recruiting | Not stated | 2026-04-23 | NCT06140992 | |
| Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Phase 3 | 2026-03-06 | NCT05871099 | |
| QL1706 Plus Chemotherapy as Neoadjuvant Therapy for Locally Advanced Cervical Cancer: A Phase II Trial | Neoadjuvant Treatment for Locally Advanced Cervical Cancer | Recruiting | Phase 2 | 2025-12-16 | NCT07286253 | |
| QL1706 Combined With Chemotherapy and Anlotinib for the Treatment of Recurrent Ovarian Cancer | Treatment of Recurrent Ovarian Cancer | Recruiting | Phase 2 | 2025-12-16 | NCT07286240 | |
| Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Recruiting | Phase 3 | 2025-12-09 | NCT07188584 | |
| GVM±R in Patients With Relapsed or Refractory Aggressive NHL. | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mature T-cell and NK-cell non-Hodgkin lymphoma, neoplasm | Recruiting | Phase 2 | 2025-05-14 | NCT06244368 | |
| Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Active, not recruiting | Phase 2 | 2025-04-02 | NCT04517214 | |
| Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whole Slide Imaging and MRI | Distant Metastasis; Nasopharyngeal Cancinoma (NPC) | Recruiting | Not stated | 2025-02-25 | NCT06831357 | |
| A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC) | Head and Neck Neoplasms, Lymph Node Metastasis, Lymphatic Metastasis, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplastic Processes, Otorhinolaryngologic Neoplasms, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Recruiting | Not stated | 2025-02-17 | NCT06829147 | |
| GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Active, not recruiting | Phase 3 | 2025-01-13 | NCT03840421 | |
| A Prospective, Non-interventional Cohort Study of Subsolid Pulmonary Nodules | Multiple Pulmonary Nodules, Neoplasms by Site, Thoracic Neoplasms, lung disorder, lung neoplasm, neoplasm, pulmonary coin lesion, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Not stated | 2024-12-02 | NCT06458673 | |
| Early Application of Memantine and Pioglitazone to Protect Cognitive Function After Radiotherapy | Cognition Disorders, Cognitive Dysfunction, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cognitive disorder, injury, psychiatric disorder, radiation injury, radiation-induced disorder | Not yet recruiting | Phase 2 | 2024-09-19 | NCT06594172 | |
| Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, mouth disorder, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease, stomatitis | Recruiting | Not applicable | 2024-08-07 | NCT05892354 | |
| HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Non-Muscle Invasive Bladder Neoplasms, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, epithelial neoplasm, neoplasm, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Not yet recruiting | Phase 3 | 2024-03-25 | NCT06327932 | |
| Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Recruiting | Phase 3 | 2023-12-15 | NCT06092957 | |
| AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Not stated | 2023-09-28 | NCT06035250 | |
| Sintilimab+Bevacizumab+TACE vs. Lenvatinib+TACE for Advanced HCC | Hepatocellular Carcinoma Non-resectable | Recruiting | Phase 3 | 2023-08-14 | NCT05985798 | |
| PD-1 Inhibitor Therapy Versus Radiotherapy in pCR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Recruiting | Phase 3 | 2023-08-08 | NCT05980715 | |
| Biomarker Analysis of HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With Peritoneal Metastasis | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Not yet recruiting | Not stated | 2022-12-22 | NCT05661110 | |
| HIPEC Combined With Sintilimab for Gastric Cancer With Peritoneal Metastasis | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Not yet recruiting | Phase 2 | 2022-12-16 | NCT05648487 |